US 10,376,564 B2
Interleukin-2 for treating food allergy
David Klatzmann, Paris (FR); and Bertrand Bellier, Paris (FR)
Assigned to SORBONNE UNIVERSITE, Paris (FR); ASSISTANCE PUBLIQUE—HOPITAUX DE PARIS, Paris (FR); and CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, Paris (FR)
Appl. No. 15/124,734
Filed by SORBONNE UNIVERSITE, Paris (FR); ASSISTANCE PUBLIQUE—HÔPITAUX DE PARIS, Paris (FR); and CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, Paris (FR)
PCT Filed Mar. 10, 2015, PCT No. PCT/EP2015/054991
§ 371(c)(1), (2) Date Sep. 9, 2016,
PCT Pub. No. WO2015/135956, PCT Pub. Date Sep. 17, 2015.
Claims priority of application No. 14305348 (EP), filed on Mar. 11, 2014.
Prior Publication US 2017/0020962 A1, Jan. 26, 2017
Int. Cl. A61K 38/16 (2006.01); A61K 38/20 (2006.01); A61K 9/00 (2006.01); A61K 39/35 (2006.01); A61K 39/00 (2006.01)
CPC A61K 38/2013 (2013.01) [A61K 9/0053 (2013.01); A61K 38/20 (2013.01); A61K 39/35 (2013.01); A61K 2039/542 (2013.01); A61K 2039/55533 (2013.01)] 19 Claims
 
1. A method for treating a food allergy in a subject comprising administering Interleukin-2 (IL-2) to said subject, wherein IL-2 is administered: (i) subcutaneously at a dosage of less than 5 MIU/day, (ii) orally at a dosage of between 0.5 and 10 MIU/day or (iii) intranasally at a dosage of between 0.5 and 5 MIU/day.